Your browser doesn't support javascript.
loading
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer.
Mizuno, Takaaki; Kojima, Yuki; Yonemori, Kan; Yoshida, Hiroshi; Sugiura, Yukiko; Ohtake, Yohei; Okuma, Hitomi S; Nishikawa, Tadaaki; Tanioka, Maki; Sudo, Kazuki; Shimomura, Akihiko; Noguchi, Emi; Kato, Tomoyasu; Shimoi, Tatsunori; Uno, Masaya; Ishikawa, Mitsuya; Fujiwara, Yasuhiro; Ohe, Yuichiro; Tamura, Kenji.
Affiliation
  • Mizuno T; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Kojima Y; The Jikei University Graduate School of Medicine, Tokyo 105-8461, Japan.
  • Yonemori K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Yoshida H; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Sugiura Y; Department of Pathology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Ohtake Y; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Okuma HS; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Nishikawa T; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Tanioka M; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Sudo K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Shimomura A; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Noguchi E; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Kato T; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Shimoi T; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Uno M; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Fujiwara Y; Department of Gynecology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Ohe Y; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo 104-0045, Japan.
  • Tamura K; The Jikei University Graduate School of Medicine, Tokyo 105-8461, Japan.
Oncol Lett ; 20(6): 336, 2020 Dec.
Article in En | MEDLINE | ID: mdl-33123247
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncol Lett Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Oncol Lett Year: 2020 Document type: Article Affiliation country: Country of publication: